Can a laser microscope match the gold standard for spotting lung cancer during a biopsy?

NCT ID NCT07725510

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study compares two methods for quickly analyzing lung tissue samples during a bronchoscopy: confocal laser endomicroscopy (CLE), which uses a laser to scan the tissue, and rapid on-site evaluation (ROSE), where a cytologist examines cells under a microscope. The goal is to see if CLE can accurately detect cancer in small lung lesions without destroying the tissue, potentially replacing ROSE. Thirty participants with suspicious lung nodules will have their biopsy samples analyzed by both methods, and the results will be checked against the final lab diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If CLE proves as accurate as ROSE, it could offer a non-consumptive, real-time diagnostic method for lung biopsies, potentially speeding up diagnosis and preserving tissue for further testing.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not generalize. CLE requires specialized equipment and expertise, which could limit its widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL PULMONARY LESIONS (PPLS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163

    RECRUITING

    Guangzhou, Guangdong, 510100, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.